Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jan 24;10(2):180.
doi: 10.3390/biom10020180.

Inhibitory Activity of Flavonoids, Chrysoeriol and Luteolin-7- O-Glucopyranoside, on Soluble Epoxide Hydrolase from Capsicum chinense

Affiliations

Inhibitory Activity of Flavonoids, Chrysoeriol and Luteolin-7- O-Glucopyranoside, on Soluble Epoxide Hydrolase from Capsicum chinense

Jang Hoon Kim et al. Biomolecules. .

Abstract

: Three flavonoids derived from the leaves of Capsicum chinense Jacq. were identified as chrysoeriol (1), luteolin-7-O-glucopyranoside (2), and isorhamnetin-7-O-glucopyranoside (3). They had IC50 values of 11.6±2.9, 14.4±1.5, and 42.7±3.5 µg/mL against soluble epoxide hydrolase (sEH), respectively. The three inhibitors (1-3) were found to non-competitively bind into the allosteric site of the enzyme with Ki values of 10.5±3.2, 11.9 ±2.8 and 38.0±4.1 µg/mL, respectively. The potential inhibitors 1 and 2 were located at the left edge ofa U-tube shape that contained the enzyme active site. Additionally, we observed changes in several factors involved in the binding of these complexes under 300 K and 1 bar. Finally, it was confirmed that each inhibitor, 1 and 2, could be complexed with sEH by the "induced fit" and "lock-and-key" models.

Keywords: flavonoids; induced fit; lock-and-key; non-competitive mode; soluble epoxide hydrolase.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
The structure of flavonoid derivatives (13).
Figure 2
Figure 2
Inhibitory activities of inhibitors 13 on sEH (A). Lineweaver–Burk plots (B,D) and Dixon plots (E,F) for the inhibition of sEH by 13.
Figure 2
Figure 2
Inhibitory activities of inhibitors 13 on sEH (A). Lineweaver–Burk plots (B,D) and Dixon plots (E,F) for the inhibition of sEH by 13.
Figure 3
Figure 3
Predicted docking poses of 1 (green) and 2 (blue) into sEH (A). The hydrogen bond (B) and π-π interaction (C) of sEH with 1. The hydrogen bond (D) and π-π interaction (E) between sEH and 2.
Figure 3
Figure 3
Predicted docking poses of 1 (green) and 2 (blue) into sEH (A). The hydrogen bond (B) and π-π interaction (C) of sEH with 1. The hydrogen bond (D) and π-π interaction (E) between sEH and 2.
Figure 4
Figure 4
Superpositions of inhibitors 1 (A) and 2 (B) against sEH for 1 ns (red: 0, orange: 1, yellow: 2, green: 3, forest green: 4, cyan: 5, blue: 6, conflower blue: 7, purple: 8,magenta: 9, and black: 10 ns). The potential (C), RMSD (D), and hydrogen bond numbers (E,F) of 1 and 2 with sEH. The distance (G,H) of compounds 1 and 2 with key amino acids, respectively.

References

    1. Batchu S.N., Lee S.B., Samokhvalov V., Chaudhary K.R., El-Sikhry H., Weldon S.M., Seubert J.M. Novel soluble epoxide hydrolase inhibitor protects mitochondrial function following stress. Can. J. Physiol. Pharmacol. 2012;90:811–823. doi: 10.1139/y2012-082. - DOI - PubMed
    1. Manickam M., Pillaiyar T., Boggu P., Venkateswararao E., Jalani H.B., Kim N.-D., Lee S.K., Jeon J.S., Kim S.K., Jung S.-H. Discovery of enantioselectivity of urea inhibitors of soluble epoxide hydrolase. Eur. J. Med. Chem. 2016;117:113–124. doi: 10.1016/j.ejmech.2016.04.015. - DOI - PubMed
    1. Imig J.D., Hammock B.D. Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases. Nat. Rev. Drug Discov. 2009;8:794–805. doi: 10.1038/nrd2875. - DOI - PMC - PubMed
    1. Newman J.W., Morisseau C., Hammock B.D. Epoxide hydrolases: their roles and interactions with lipid metabolism. Prog. Lipid Res. 2005;44:1–51. doi: 10.1016/j.plipres.2004.10.001. - DOI - PubMed
    1. Zhao T.-T., Wasti B., Xu D.-Y., Shen L., Du J.-Q., Zhao S.-P. Soluble epoxide hydrolase and ischemic cardiomyopathy. Int. J. Cardiol. 2012;155:181–187. doi: 10.1016/j.ijcard.2011.05.067. - DOI - PubMed

MeSH terms

LinkOut - more resources